National Storage Mechanism | Additional information

RNS Number : 0712S

Proteome Sciences PLC

16 December 2016

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESⁱ


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ⁱⁱ		PROTEOME SCIENCES PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights			YES
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: ⁱⁱⁱ	VULPES LIFE SCIENCES FUND
4. Full name of shareholder(s) (if different from 3.):^iv
5. Date of the transaction and date on which the threshold is crossed or reached: ^v	14 DECEMBER 2016
6. Date on which issuer notified:	15 DECEMBER 2016
7. Threshold(s) that is/are crossed or reached: ^{vi, vii}	18%

8. Notified details:

A: Voting rights attached to shares ^{viii, ix}

Class/type of
shares

if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of voting rights ^x

Direct

Direct ^xi

Indirect ^xii

Direct

Indirect

GB0003104196

36,573,125

52,973,125

18.00%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date ^xiii

Exercise/
Conversion Period ^xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ^{xv, xvi}

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date ^xvii

Exercise/
Conversion period ^xviii

Number of voting rights instrument refers to

% of voting rights ^{xix, xx}

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

52,973,125

18.00%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ^xxi


Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:	executive.pa@proteomics.com
14. Contact name:	Victoria Birse
15. Contact telephone number:

Note: Annex should only be submitted to the FCA not the issuer
Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)	VULPES LIFE SCIENCES FUND
Contact address (registered office for legal entities)	c/o Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands
Phone number & email
Other useful information (at least legal representative for legal persons)

B: Identity of the notifier, if applicable
Full name	Stephen Diggle
Contact address	One George Street #07-03 Singapore 049145
Phone number & email	Tel: (65) 6538 1998 (Main) Email: sdiggle@vulpesinvest.com
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)	Director

C: Additional information
Email address: Complete the required TR-1 form and email it to: Major shareholdings majorshareholdings@fca.gov.uk Fax number: You can print the TR-1 form, complete it and fax it to: 020 7066 0050
For notes on how to complete form TR-1 please see the FCA website.

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLGGGAPPUPQUBQ